Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

BACKGROUND: T cell-based immunotherapies using chimeric antigen receptors (CAR) or bispecific antibodies (BsAb) have produced impressive responses in hematological malignancies. However, major hurdles remained, including cytokine release syndrome, neurotoxicity, on-target off-tumor effects, reliance...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Immunother Cancer
Hoofdauteurs: Park, Jeong A, Santich, Brian H, Xu, Hong, Lum, Lawrence G, Cheung, Nai-Kong V
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2021
Onderwerpen:
Immune Cell Therapies and Immune Cell Engineering
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126293/
https://ncbi.nlm.nih.gov/pubmed/33986124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002222
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items